Alzheimer's Screening

Alzheimer's disease is a disease that destroys brain cells. The destruction of cells causes a decline in mental functions that affect memory, thinking, language and behavior. While the disease can occur in people in their 40s and 50s, it most commonly affects those aged 65 and older.

A PET/CT scan can show the brain's biological changes from Alzheimer's disease before any other diagnostic test. This exam can even detect Alzheimer's disease several years before the onset of symptoms. Detection of Alzheimer's disease at its first indication allows for:

  • Early drug therapy to slow the progression of the disease
  • Future planning before loss of mental capacity
  • Accurate diagnosis of Alzheimer’s or another form of dementia versus chronic depression and normal aging

The PET/CT scanning system combines the physical brain images of CT with the functional brain images of PET that is an essential tool for the early detection, treatment and monitoring of Alzheimer's disease. Using specialized contrast agents, the PET/CT provides exact information about the location and activity of altered cells that are associated with this disease.